title: MHC-based diagnostics and therapeutics - clinical applications for disease-linked genes.
authors: Corixa Corporation (formerly Anergen Inc.), Redwood City, CA, USA.
authors: M C
authors: MC
authors: Howard
authors: E G
authors: EG
authors: Spack
authors: K
authors: K
authors: Choudhury
authors: T F
authors: TF
authors: Greten
authors: J P
authors: JP
authors: Schneck
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000628:therapy; D015683:Gene Products, gag / Q000378:metabolism; D016356:Gene Products, tax / Q000378:metabolism; D015789:HLA-A2 Antigen; D006649:Histocompatibility Antigens / Q000627:therapeutic use*; D015368:Human T-lymphotropic virus 1; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007167:Immunotherapy / Q000639:trends*; D008285:Major Histocompatibility Complex / Q000276:immunology*; D051379:Mice; D015493:Paraparesis, Tropical Spastic / Q000175:diagnosis / Q000821:virology; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D015683:Gene Products, gag; D016356:Gene Products, tax; D015789:HLA-A2 Antigen; D006649:Histocompatibility Antigens; D007074:Immunoglobulin G